BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3303928)

  • 21. Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features.
    Clarke BL; Wynne AG; Wilson DM; Fitzpatrick LA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):479-90. PubMed ID: 7586624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary hyperparathyroidism as a palpable intrathyroid parathyroid gland in a patient with hypophosphatemic osteomalacia.
    Su DH; Liao KM; Chang YC; Tsai KS
    J Bone Miner Metab; 2006; 24(2):114-7. PubMed ID: 16502117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-induced osteomalacia masking primary hyperparathyroidism.
    Elfenbein DM; Weber TJ; Scheri RP
    Surgery; 2012 Dec; 152(6):1256-8. PubMed ID: 23158192
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumor-induced osteomalacia.
    Kaul M; Silverberg M; Dicarlo EF; Schneider R; Bass AR; Erkan D
    Clin Rheumatol; 2007 Sep; 26(9):1575-9. PubMed ID: 17225058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogenic osteomalacia associated with a meningeal phosphaturic mesenchymal tumor. Case report.
    David K; Revesz T; Kratimenos G; Krausz T; Crockard HA
    J Neurosurg; 1996 Feb; 84(2):288-92. PubMed ID: 8592237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
    Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM
    Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypophosphatemic osteomalacia associated phosphaturic mesenchymal tumor of bone: report of a case].
    Gong LH; Sun XQ; Xi Y; Ding Y; Huang XY
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):201-2. PubMed ID: 23769443
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous hypercalcemia in patients undergoing dialysis. Etiologic and therapeutic considerations.
    Piraino BM; Rault R; Greenberg A; Dominguez JH; Wallia R; Houck P; Segre GV; Chen T; Foti FM; Puschett JB
    Am J Med; 1986 Apr; 80(4):607-15. PubMed ID: 3963041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study.
    Zavvos V; Fyssa L; Papasotiriou M; Papachristou E; Ntrinias T; Savvidaki E; Goumenos DS
    Exp Clin Transplant; 2018 Jun; 16(3):287-293. PubMed ID: 29108515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptomatic osteomalacia after jejunoileal bypass surgery in a patient with primary hyperparathyroidism. A study of the change in bone morphology and vitamin D metabolites before and during treatment.
    Taylor HC; Teitelbaum SL; Lambert PW
    Gastroenterology; 1983 Sep; 85(3):735-42. PubMed ID: 6603388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful CT guided cryoablation of phosphaturic mesenchymal tumor in the soft tissues causing tumor-induced osteomalacia: a case report.
    Cowan S; Lozano-Calderon SA; Uppot RN; Sajed D; Huang AJ
    Skeletal Radiol; 2017 Feb; 46(2):273-277. PubMed ID: 27921126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypophosphatemic osteomalacia: association with prostatic carcinoma.
    Lyles KW; Berry WR; Haussler M; Harrelson JM; Drezner MK
    Ann Intern Med; 1980 Aug; 93(2):275-8. PubMed ID: 7406380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Tertiary" hyperparathyroidism and apparent "cure" of vitamin-D-resistant rickets after removal of an ossifying mesenchymal tumor of the pharynx.
    Olefsky J; Kempson R; Jones H; Reaven G
    N Engl J Med; 1972 Apr; 286(14):740-5. PubMed ID: 4337228
    [No Abstract]   [Full Text] [Related]  

  • 36. [Detection of the primary tumor site in tumor-induced osteomalacia by indium-111 octreotide scintigraphy: a case report].
    Takahashi M; Toru S; Ota K; Izumiyama H; Yokota T; Mizusawa H
    Rinsho Shinkeigaku; 2008 Feb; 48(2):120-4. PubMed ID: 18326305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-induced osteomalacia.
    Schapira D; Ben Izhak O; Nachtigal A; Burstein A; Shalom RB; Shagrawi I; Best LA
    Semin Arthritis Rheum; 1995 Aug; 25(1):35-46. PubMed ID: 8525389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of calcitriol and inorganic phosphate therapy before cure of oncogenous osteomalacia by resection of a mixed mesenchymal tumor.
    Taylor HC; Santa-Cruz D; Teitelbaum SL; Bergfeld MA; Whyte MP
    Bone; 1988; 9(1):37-43. PubMed ID: 3377920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary hyperparathyroidism in nutritional osteomalacia.
    Rizvi SN; Vaishinava H
    J Indian Med Assoc; 1975 Apr; 64(8):199-204. PubMed ID: 1080494
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies in a patient with tumor-induced hypophosphatemic osteomalacia.
    Ryan WG; Gitelis S; Charters JR
    Calcif Tissue Int; 1986 Jun; 38(6):358-62. PubMed ID: 3089559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.